上腺素诱导高度血清性卵巢癌前体细胞的耐药性
Hunter D Reavis1,2,3, Stefan M Gysler1, Grace B McKenney1
1Penn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology.
JCI insight
|January 25, 2024
概括
上腺素 (NE) 促进了早期高度血清癌 (HGSC) 的发展,使得前瘤病变能够独立于 anchorage. 使用普拉诺洛尔阻断β-上腺素受体 (β-AR) 阻止了这种NE驱动的效果,这表明了新的治疗点.
科学领域:
- 妇科瘤学 妇科瘤学
- 癌症的发病因子 癌症的发病因子
- 瘤微环境 瘤微环境
背景情况:
- 高度血清瘤 (HGSC) 是一种致命的妇科癌症,往往由于晚期诊断和化疗抵抗,结果不佳.
- 瘤内化和瘤微环境越来越被认为是HGSC进展的关键因素.
- 卵巢的诺亚上腺素 (NE) 水平在排卵和绝经期间上升,并且已知NE会恶化先进的HGSC,但其在早期疾病中的作用尚不清楚.
研究的目的:
- 研究上腺素 (NE) 在高度血清癌 (HGSC) 早期病原发生中的作用.
- 为了确定NE是否诱导卵巢的先性输卵管表皮质 (FTE) 病变的固定独立性和微转移.
主要方法:
- 在超低附着 (ULA) 培养中利用输卵管表皮 (FTE) 细胞系来评估固独立性.
- 给药的上腺素 (NE) 和使用β-上腺素受体 (β-AR) 阻断剂 (propranolol) 来评估受体依赖性.
- 分析了殖民地刺激因子2 (CSF2) 的表达,以了解阿诺基的抵抗机制.
主要成果:
- 上腺素 (NE) 治疗使FTE细胞能够在ULA培养中存活,表明结独立,以β-上腺素受体 (β-AR) 依赖的方式.
- 由生理NE诱导的球形形成和细胞活力被β-AR对手propranolol阻断.
- NE诱导的阿诺基基抗性与殖民地刺激因子2 (CSF2) 的下调相关.
结论:
- 上腺素 (NE) 在促进早期HGSC发育方面发挥着至关重要的作用,通过赋予先前瘤病变的固定独立性.
- 向β-上腺素受体 (β-AR) 或涉及CSF2的途径可能为HGSC预防和拦截提供新的策略.
- 卵巢衍生的NE可能是HGSC发病的初始阶段的关键调节者.
更多相关视频
相关概念视频
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Oogenesis
63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K


